ClinicalTrials.gov
ClinicalTrials.gov Menu

Compliance With Once Daily Glaucoma Medication

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00333463
Recruitment Status : Completed
First Posted : June 5, 2006
Last Update Posted : November 18, 2016
Sponsor:
Collaborators:
Johns Hopkins University
University of Pennsylvania
Information provided by (Responsible Party):
Alcon Research

Study Description
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
A study to examine patient compliance with once daily glaucoma medication

Condition or disease Intervention/treatment
Compliance Behavioral: Intervention

Study Design
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Estimated Enrollment : 700 participants
Time Perspective: Retrospective
Official Title: Compliance With Once Daily Glaucoma Medication
Study Start Date : June 2006
Actual Primary Completion Date : September 2007
Actual Study Completion Date : September 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Glaucoma
U.S. FDA Resources

Groups and Cohorts
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Intervention group
The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
 Behavioral: Intervention
The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
Non-Intervention Group
The control group was told to take drops as prescribed and received no additional intervention.


Outcome Measures
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Eligibility Criteria
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Primary open angle glaucoma or ocular hypertension patients
Criteria

Inclusion Criteria:

  • Primary open angle glaucoma or ocular hypertension patients

Exclusion Criteria:

Contacts and Locations
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00333463


Locations
United States, Texas
Ft. Worth
Ft. Worth, Texas, United States, 76134
Sponsors and Collaborators
Alcon Research
Johns Hopkins University
University of Pennsylvania
Investigators
Study Director: David Friedman, MD Study Director
More Information
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications of Results:

Responsible Party: Alcon Research
ClinicalTrials.gov Identifier: NCT00333463     History of Changes
Other Study ID Numbers: CMS-06-03
First Posted: June 5, 2006    Key Record Dates
Last Update Posted: November 18, 2016
Last Verified: March 2010

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases